Related Experiment Video
Updated: Jul 8, 2026

05:51
A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
Published on: March 17, 2023
Sensitive and selective tumor imaging with novel and highly activatable fluorescence probes
1Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan. urano@mol.f.u-tokyo.ac.jp <urano@mol.f.u-tokyo.ac.jp>
Summary
Activatable optical fluorescence imaging offers a superior method for in vivo tumor detection. This technique enhances signal intensity specifically at tumor sites, overcoming limitations of other imaging modalities.
Area of Science:
- Biomedical imaging
- Optical diagnostics
- Molecular imaging
Background:
- In vivo tumor imaging is crucial for medical diagnostics.
- Current methods like PET and MRI lack signal amplification at tumor sites.
- Optical fluorescence imaging presents an opportunity for enhanced tumor visualization.
Purpose of the Study:
- To review recent strategies for activatable optical fluorescence imaging of tumors.
- To highlight the advantages of activatable optical imaging over other modalities.
- To discuss signal amplification mechanisms in tumor detection.
Main Methods:
- Review of recent scientific literature on activatable optical fluorescence imaging.
- Analysis of strategies for signal enhancement in tumor detection.
- Comparative assessment of optical imaging versus PET and MRI.
Main Results:
- Activatable optical fluorescence imaging demonstrates significant signal increase upon tumor site detection.
- These strategies overcome the limitations of non-activatable imaging techniques.
- Optical methods show promise for sensitive and selective in vivo tumor visualization.
Conclusions:
- Activatable optical fluorescence imaging provides enhanced sensitivity and selectivity for tumors.
- This approach offers a significant advantage over conventional imaging modalities.
- Future research should focus on developing novel activatable probes for clinical translation.

